The cardioprotective effects of Fruitflow® against Doxorubicin-induced toxicity in rat cardiomyoblast cells H9c2 (2−1) and high-fat diet-induced dyslipidemia and pathological alteration in cardiac tissue of Wistar Albino rats
Our findings suggest Fruitflow® may have cardioprotective effects, making it a potential treatment option for cardiac ailments. Larger-scale clinical trials were recommended further to determine the efficacy and safety of Fruitflow® as a potential therapeutic agent for cardiac diseases, potentially in combination with other cardioprotective medications.
Authors
- Antara Banerjee (ORCID: https://orcid.org/0000-0002-5519-6878)
- Surajit Pathak (ORCID: https://orcid.org/0000-0002-7306-1272)
- Asim K. Duttaroy (ORCID: https://orcid.org/0000-0003-1619-3778)
- Ganesan Jothimani (ORCID: https://orcid.org/0000-0003-3031-5620)
- Diptimayee Das
Institutions
- University of Oslo (NO)
- Chettinad Academy of Research and Education (IN)
Publication Details
- Journal
- Biomedicine & Pharmacotherapy
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1016/j.biopha.2024.117607
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00